Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Impax Labs Challenges Patent on Avanir’s Nuedexta

By Pharmaceutical Processing | September 1, 2011

HAYWARD, Calif. (AP) — Impax Laboratories Inc. said Wednesday it is challenging the patents on Avanir Pharmaceuticals Inc.’s drug Nuedexta, and it said Avanir has filed a patent infringement lawsuit.

Avanir began selling Nuedexta in February. The drug is approved as a treatment for pseudobulbar affect, a condition that involves involuntary emotional outbursts like laughing or crying. It is associated with brain disease or injury. Impax said U.S. sales of Nuedexta since its launch totaled $3.6 million.

Impax said Avanir, of Aliso Viejo, Calif., filed a patent infringement lawsuit in Monday in the District of Delaware. As a result of the lawsuit, the Food and Drug Administration will not approve Impax’s application for 30 months or until the court makes a ruling on the patents, whichever comes first.

Avanir said on Aug. 11 that it is suing two other companies that want to market generic versions of Nuedexta. Par Pharmaceutical Cos. and Actavis Inc. had also asked the FDA to approve their generics.

Shares of Impax rose 35 cents to $19.75 in afternoon trading. Avanir shares fell 14 cents, or 4.7 percent, to $2.82.

 

 

Related Articles Read More >

Doctor, woman patient and tablet for consulting with results, medical info and talk for healthcare with mockup space. Japanese medic, digital touchscreen or show video for surgery, wellness or advice.
Putting patients first in clinical trials
Confidently navigate the transition from bench to batch
Merck
FDA approves Merck’s Winrevair to treat pulmonary arterial hypertension
kobayashi pharmaceutical logo
Report: Japan health authorities investigate Kobayashi Pharmaceutical factory after five deaths
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE